Elevance Health (ELV) has a profit margin of 2.47%, below the Finance sector average of 17.16%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for ELV is 2.47% as of June 2026. That compares with 0.69% in the prior-year period — up 257.5% year over year. That is below the Finance sector average of 17.16%. Investors often review this figure alongside Elevance Health's historical trend and sector peers before judging valuation or financial health.
Over the past year, ELV's profit margin moved from 0.69% to 2.47% — a 257.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Elevance Health's valuation or profitability profile.
Against Finance companies, ELV currently prints 2.47% for profit margin, while the sector average sits near 17.16%. That is roughly 85.6% below the sector mean. Large gaps often invite a closer look at Elevance Health's growth, margins, and balance sheet.
Profit Margin shows how effectively Elevance Health converts resources into returns. At 2.47%, ELV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 0.69% in the prior-year period — up 257.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ELV's profit margin (2.47%), review year-over-year change from 0.69%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.